Jie Dai
- Immunology top 5%
-
- Lung Cancer Diagnosis and Treatment 28
- Lung Cancer Treatments and Mutations 15
- Tracheal and airway disorders 9
- Pleural and Pulmonary Diseases 9
- Cell Biology top 5%
- Microbiology top 10%
- Oncology top 10%
- Lung Cancer Research Studies 9
-
- Epigenetics and DNA Methylation 11
- Cancer-related gene regulation 9
-
- Selenium in Biological Systems 10
- Co-authors
- Zihai LiBei LiuYi YangGening JiangHong ZhengLeo LefrançoisPramod K. SrivastavaDavid J. Zammit
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Advanced Materials (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Jie Dai
95 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 113
- Immunology 803
- Pulmonary and Respiratory Medicine 611
- Cell Biology 243
- Microbiology 11
- Oncology 400
Countries citing papers authored by Jie Dai
This map shows the geographic impact of Jie Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Dai more than expected).
Fields of papers citing papers by Jie Dai
This network shows the impact of papers produced by Jie Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Dai. The network helps show where Jie Dai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jie Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 36 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 43 | |
| 9 | 2023 | 3 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 8 | |
| 12 | 2020 | 27 | |
| 13 | 2020 | 26 | |
| 14 | 2020 | 3 | |
| 15 | 2019 | 62 | |
| 16 | 2016 | 7 | |
| 17 | 2007 | 41 | |
| 18 | 2006 | 117 | |
| 19 | 2003 | 138 | |
| 20 | 2001 | 137 |
About Jie Dai
Jie Dai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 105 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (28 papers), Lung Cancer Treatments and Mutations (15 papers), Epigenetics and DNA Methylation (11 papers), Selenium in Biological Systems (10 papers), Tracheal and airway disorders (9 papers), Cancer-related gene regulation (9 papers), Pleural and Pulmonary Diseases (9 papers) and Lung Cancer Research Studies (9 papers). The work is most often cited by research in Immunology (803 citations), Pulmonary and Respiratory Medicine (611 citations) and Cell Biology (243 citations). Jie Dai has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Zihai Li, Bei Liu, Yi Yang, Gening Jiang, Hong Zheng, Leo Lefrançois, Pramod K. Srivastava, David J. Zammit, Shaoli Sun and Anthony T. Vella. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.